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Abstract
The usage of 1D and 3D models to simulate drug transport through the inner ear is a prominent
method in cochlear fluid pharmacokinetics. However, the data used to create these models, is often
based on invasive sampling methods that limit the spatial resolution given the size of the cochlear
compartments within which solute can be measured. In this work by leveraging 3-D registered micro-
Computed Tomography (µCT) scans of the murine cochlea that have been taken as iodinated contrast
agent is delivered to it, we extract transport parameters and simulate a forward 1D model that allows
variable and pulsatile delivery profiles over time and can be extended to the use of other drugs.
Our 1D model may be used to simulate transport of a compound within the primary scalae or com-
partments of the cochlea namely: scala tympani (ST), scala vestibuli (SV) and scala media (SM). We
investigate extracting transport parameters of the 1D model for the iodinated contrast agent (Iopami-
dol), such as the concentration dependent diffusion coefficient, along with permeabilities across mem-
branes that represent transfer between the primary scalae and clearance out to blood. Flow rates that
change over time are also learned, to account for leakage due to experimental set up. Dimensions of
cochlear structures considered in the model, and empirical concentration profiles are extracted non-
invasively over regional cross sections of a set of registered µCT scans of the mouse cochlea while an
Iodinated contrast agent (Iopamidol) is delivered to it. Given initial estimates of the transport parame-
ters, we use a simple iterative gradient descent approach to minimize the mean-squared error between
our predicted concentrations from the 1D model and those derived empirically. We put forth a method
to illustrate that once these parameters are learned for the contrast agent, they can be adjusted to sim-
ulate the delivery of other compounds, and can also be used to study various infusion paradigms to
maintain a suitable therapeutic window for optimal, effective and safe administration of a drug. The
results are important in the development of such paradigms for the prevention and treatment of acute
and chronic types of hearing loss.
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1 Introduction
The mammalian inner ear consists of three main structures, the semicurcular canals, the vestibule and
the cochlea. While the vestibule and the canals are important for vestibular functions, the cochlea is
important for auditory fucntions. The cochlea is a coiled bony structure that handles transduction of
mechanical sound waves to a neural response. It is comprised of various compartments: scala tympani
(ST), scala vestibuli (SV) and scala media (SM). The mechanical stimulation of the membrane between ST
and SM and the structures on it, result in the transduction of mechanical to electrical (neural) response.
The hair cells on the membrane and the structures associated with it are important components in this
transduction, and most drug based therapeutic interventions are aimed at delivery to these cells. Drug
delivery can either be systemic (oral, intramuscular, intravenous) or, directed or local delivery, but site
directed delivery is usually preferred since it avoids issues with overcoming the blood-labyrinth barrier
and systemic side effects.
1.1 Current uses for inner ear drug delivery
Drug delivery to the inner ear has the potential to treat auditory and vestibular diseases [1]. The use of
gentamicin for the treatment of Meniereâs, a vestibular disease is one of the more notable examples of
drugs being delivered to the inner ear. Another one is the use of steroids for sudden sensorineural hearing
loss, an auditory disease. These drugs are more commonly delivered to the middle ear so that they may
be absorbed by the inner ear through the round and oval window membrane [2]. RNA Interference and
Stem-cell therapy are promising technologies that are being developed but need direct delivery to the
inner ear[3]. For the purpose of delivery, microsystem technologies for cochlear implants are an emerging
development so that drugs may be applied more precisely and for longer durations and with controlled
infusion profiles [1, 2]. Due to space constraints, and the difficulties associated with measuring drug levels
in the inner ear, application protocols tend to be empirically based with large ranges of suggested doses
as in the case of gentamicin [4]. This also leads to wide variations in reports of loss of hearing experienced
by patients. These variations warrant the need for modelling pharmacokinetics in the inner ear to better
understand the distribution of drugs within it.
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1.2 Methods in sampling
Sampling refers not only to the sampling of fluid concentrations within the cochlea but also to the sam-
pling of cochlear structure and compartment dimensions.
1.2.1 Sampling of drug concentration
A common method in the study of inner ear pharmacokinetics estimates the drug concentration based on
functional assessment of hearing [5]. It relies on the assumption that the concentration is proportional to
the physiological response of the drug and that the sensitivity of cochlear hair cells is uniform throughout
the inner ear. The basilar membrane responds to different frequencies in the range of hearing along its
length. Audiograms are plotted at different points in time along the course of drug delivery, and observa-
tions are made based on shifts in hearing related to concentration. A tonotopic map is used to correlate
the location in space along the basilar membrane to the frequency shift observed. For the evaluation of
various infusion protocols, the indirect methods provide useful qualitative information but only provide
estimates of concentration profiles.
Another approach involves markers being applied to the fluid spaces and their spread documented
using ion selective electrodes or fluid samples taken from the basal or apical turns of the cochlea [6, 7, 8].
These methods are invasive and may interfere with the concentration values. While the spatial density
depends on number of electrodes used, the size of the structures being studied limits the number to 2 or
3. Their applicability further reduces in smaller animals.
Haghpanahi et al. sampled concentrations at 5 points along the length of SV and ST using a set of 2D
uCT images [9]. Since they had low resolution, they were registered to Santi et al’s labelled atlas scans [10].
This method is non-invasive and can be extended to provide higher spatial resolution.
1.2.2 Sampling of cochlear dimensions
Methods for extractions of cochlear dimensions so far have been based on Magnetic resonance microscopy
(MRM) scans of chochleae of multiple species that were treated and fixed with various agents over a few
days [11, 12]. Once treated the MRM scans were taken of the excised temporal bones and the different
regions of the cochleae were segmented from each slice using density thresholds and investigator inter-
vention. Planes were interpolated by rotating them about the central axis of the helical cochlear structure
and extracting the areas about the midpoint of each intersection of a scala with the plane. This method
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is invasive and does not ensure that the area extracted at each point along the length is the true cross
sectional area of the scala since it uses the helical axis (or the rotational axis) as reference. A true cross
sectional plane would be perpendicular to the medial axis of the cochlea (in this case the helix that de-
scribes the cochlea) at the point of interest.
1.3 Forward models
A good forward model would be able to provide us with close estimates of how the drug propagates, which
could allow us to tweak our rate of injection so that it results in a suitable balance between efficacy and
toxicity for each individual case. This would be particularly useful in the use of implantable pumps where
the delivery profile can be controlled.
The Washington University cochlear fluid simulator, also known as FluidSim [13], is a detailed 1D
model has been developed to simulate cochlear pharmacokinetics in a variety of small mammals and
humans with various drug delivery configurations . It divides each scala into 0.1mm sections along the
length and takes into account diffusion, interscala communications, longitudinal flow and clearance. De-
livery is allowed by various methods such as permeation through the round window, injection into the
perilymph at low rates and perfusion via a cochleostomy. A leakage with a fixed flow rate over the course
of delivery can also be considered. While the simulator is well detailed, it does have some limitations. The
diffusion coefficient is fixed and does not have the provision to be allowed to change with the concentra-
tion of the solute which is important for transport of substances at higher concentrations. It is also based
only on molecular weight and does not take into account density of the solute; this implies that different
solutes with the same molecular weight would have similar transport characteristics which may not be
the case. It makes use of average half-times that can be normalized by area to denote interscala commu-
nication, while clearance half-times are assumed to be constant along the length of the scalae. The model
provides some demos for certain drugs, with preset transfer and clearance paramaters. But to simulate
transport for a new drug, these half times need to be estimated and set by the user and experiments need
to be performed to derive clearance half-times.
Plontke et. al simulated a finite element simplified 3D model based on the guinea pig cochlea and
demonstrated the existence of substantial radial gradients across the basal turn especially for larger an-
imals [14]. These gradients are insignificant in cochlear regions of smaller cross sections or even those
of smaller animals. The model consisted of multiple straight tapered tubes connected to each other to
represent the guinea pig cochlea. The 3D structure of the model was simple. By reducing the dimension-
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ality of the geometry, it was possible to simulate a 1D model and to compare it to FluidSim. The model
works well to show the radial concentration gradients within the basal region of each scala. The parame-
ters used in the model are based on earlier derived transfer coefficients from FluidSim. They suggest that
methods to validate the radial gradients within the basal regions are few and include using ion selective
microelectrodes. The model is also suggested to be innacurate due to the simplification of the 3D struc-
ture. With the computational complexity involved, estimation of parameters becomes cumbersome since
the simulation needs to be run multiple times which leads them to suggest that reduced 1D models will
be the preferred method for use in pharmacokinetics for now. This model too does not take into account
the possibility of a concentration dependent coefficient of diffusion and is limited to demonstrating the
use of bolus or continuous delivery of drug.
1.4 Our work
Through this work we design a 1D model based on the mouse cochlea, which depends on transport pa-
rameters such as a concentration dependent diffusion coefficient, transfer coefficients between scalae
and clearance out to blood. To extract these parameters we make use of 3D registered µCT scans of the
mouse cochlea taken over time as it is infused with an iodinated contrast agent (Iopamidol) through a
cochleostomy. The registration of these scans with high spatial resolution aids in identifying membranes
and individual scalae, and provides an accurate and non-invasive method of sampling (both the concen-
trations as well as the cochlear dimensions) using the medial axes of the scalae. This does not disrupt the
natural state of transport within the cochlea. We randomly initialize the estimates of the transport pa-
rameters and optimize them with a simple gradient descent approach. The method minimizes the mean
square error between our simulations and concentration profiles extracted from 3D registered µCT scans
by adjusting the parameter estimates at a rate proportional to the rate of change of the error with respect
to that parameter. Leakage within each experiment is also estimated by this method. We extend the use
of the model by adjusting the extracted parameters to simulate profiles for other drugs and also illustrate
its use in optimizing delivery profiles for a target notational therapeutic window.
1.5 Overview
Chapter 2 starts by providing an overview of the structure of the mammalian ear and then goes on to ex-
plain the structure and functioning of the inner ear in some detail. This is followed by an explanation of
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the pharmacokinetics of the inner ear in chapter 3 and lays out the partial differential equations (PDEs)
used. Chapter 4 describes the process involved in the extraction of data in our experiments, beginning
with an outline of the surgical procedures for the delivery of contrast agent and the imaging performed
on the mouse. It then explains the process of registration followed by the concentration extraction. Chap-
ter 5 discusses the optimization technique by first addressing the discretization of the the earlier discussed
PDEs followed by the gradient descent method. Chapter 6 for the results, talks about the extracted con-
centrations and parameters learned from them. The parameters are then used to illustrate applications
of the model. We conclude with the final chapter and discuss future work within our lab.
The flowchart below provides an outline of the process that will be detailed in the thesis.
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Figure 1: The flowchart gives an overview of the process involved in the extraction of concentrations from
the µCT scans and the parameter optimization. Yellow boxes indicate processes involved in imaging the
murine cochlea and application of the calibration parameters. Blue boxes represent those processes that
involve 3D-Image Processing, which is used to segment the µCT scans and extract the corresponding
cross sectional areas and concentration profiles. Green boxes represent the optimization process in which
parameters are updated based on the rate of change of loss between the extracted concentrations and the
simulated ones generated by the forward model.
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2 The inner ear
In his book, William A. Yost describes the structure and function of the ear [15]. The inner ear per-
forms mechanical to neural transduction. The nervous system is provided with information about the
frequency, amplitude and temporal content of the sound.
Figure 2: Overview showing the outer, middle and inner ears.
Reproduced from "Microbiology of Middle Ear Infections: Do You Hear What I Hear?" Wolk, 2016, with
permission from Elsevier
While our model is based on the mouse, we describe the human cochlea since the differences between
them are mostly dimensional and the structure of the ear is similar for most mammals.
The ear is divided into external, middle and inner ears. The external or outer ear includes the pinna,
concha and the external auditory canal. The pinna and concha are used to direct sound to the external
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auditory canal which ends with the ear drum or tympanic membrane. The ear drum acts as a partition
between the external and middle ear. It is connected to the ossicles which are three bones suspended from
ligaments in the middle ear. The bones viz. malleus, incus and stapes form the ossicular chain. The stapes
is shaped like a stirrup with the footplate implanted in the oval window. The ossicular chain vibrates when
stimulated by the vibration of the tympanic membrane, thus causing vibrations in the inner ear through
the round window. The inner ear is made up of three parts the semicircular canals, the vestibule and the
cochlea. The semicircular canals affect vestibular system. The vestibule is bounded laterally by the oval
window. The cochlea is primary auditory organ of the inner ear. Since the sensory units of the auditory
and vestibular systems are the hair cells, they are the targets of corticosteroids or regenerative drugs or
protective agents. They are housed within the cochlea so an overview of the structure and functioning of
the cochlea would aid in illustrating the simplification of the pharmacokinetic model used for the forward
and inverse model.
2.1 The cochlea
The cochlea is a spiral tube of bone of decreasing diameter. Along the entire length of the cochlea, a ledge
of bone called the Osseous spiral lamina extends out of the modiolus or the central axis of the spiral. The
basilar membrane extends out from the spiral ligament and connects to the Osseous spiral lamina, di-
viding the entire canal except at the helicotrema which connects the scala tympani and scala vestibuli at
the apex. The scala tympani (ST) is the lower passage which is separated from the tympanic cavity by the
round window membrane (RW). It is connected through a bony channel called the cochlear aqueduct to
the subarachnoid space near the brain. The scala vestibuli (SV) is the upper passage which is connected
to the tympanic cavity via the footplate and oval window. The Reissner’s and basilar membranes enclose
a cochlear filled sac with endolymph. The sac is called the scala media (SM). The organ of corti lies on the
spiral lamina and the basilar membrane and include an inner tunnel of corti filled with cortilymph which
is flanked by inner and outer hair cells. The endolymph within the scala media has a higher concentration
of potassium ions than sodium ions, while the scala tympani and vestibule are filled with perilymph that
has a higher concentration of sodium ions than Potassium ions. The tips of the hair cells are in contact
with endolymph while their bases are in contact with perilymph, the differences in charges and concen-
trations of the ions between these fluids create a resting (or dc) potential difference between scala media
and scala tympani.
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Figure 3: Cross section of the cochlea showing scala tympani (ST), scala media (SM) and scala vestibuli
(SV). SV and SM are separated by Reissner’s membrane, while ST and SM are separated by the basilar
membrane and the organ of corti. The basilar membrane and organ of corti together are important struc-
tures in transduction of sound waves to electrical signals. SM is in direct contact with the stria vascularis
which is a wall of blood capillaries which is important for transport to the rest of the body.
Reproduced from "Fundamentals of Hearing" 5th Ed., William A. Yost, with permission from Elsevier
2.2 The hair cells
The hair cells have a membrane on their upper surfaces with cuticles in which the bases of smaller ‘hairs’
or cilia called stereocilia are rooted. Hair cells are located between the tectorial and basilar membrane. On
reception of mechanical sound waves, the tectorial and basilar membranes vibrate resulting in shearing
forces acting on the stereocelia. The shearing in the cilia on the IHC probably takes place due to move-
ment of the fluids, since their tips are free, while those on the OHC take place due to tectorial membrane
movement since their tips appear to be firmly attached to it. Shearing of the stereocila aids in causing
ion channels to open and close, transducing mechanical energy into electrochemical activity in the hair
cells. This is done by changing the permeability of the hair cell membranes to allow movement of Na+
and K+ ions in and out of the cell. Differences in the concentrations and charge of ions between intra
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and extracellular fluids give rise to a potential difference across the cell membrane. Adequate stimulus
changes the cell membrane permeability so that Na+ ions can flow in. Even if no stimulus is applied, a
potential difference exists across the cell membrane aka resting potential. The resting potential is nega-
tive, the flow of Na+ into the cell changes it to a less negative value, i.e. depolarization takes place. Once a
critical potential difference is reached, the cell membrane changes permeability at the next point. At the
original point, the ions move back their resting state with some undershoot (hyperpolarization). The ion
exchanges triggered down the nerve result in the propagation of action potential down the nerve.
Since drugs delivered to the cochlea are directed towards the hair cells, it is important to quantify them
to make sure the drug falls within the therapeutic window i.e. the range of values where the benefits of
the drug outweigh its toxicity.
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3 Pharmacokinetics of the inner ear
How a drug is handled by an organism’s body is complex depending on the processes of absorption, dis-
tribution, metabolism and elimination. These processes are often simultaneous and may also need to
take into account the process of liberation or delivery of the drug. The study of the time course of these
processes is referred to as pharmacokinetics.
Simplification of processes is necessary for prediction of drug behavior. This is most commonly done
with compartmental models. They are classified based on the number of compartments that are used as
an assumption for the model i.e. single, double or multi-compartment models. A single model assumes
the organ or subset of organs as being isolated from the rest of the organism’s body, this means that a part
of an organ or even the entire body can be treated as a single compartment or a single black box. Similarly
a double or multi-compartmental model assumes the body is divided into two or multiple black boxes
respectively. Our model divides the cochlea into the 3 compartments, the scala tympani, scala media
and scala vestibuli, we discuss this in more detail in this section. Solute dispersal processes in this model
are a combination of transport processes described within a compartment by diffusion and longitudinal
flow, and those describing interscala communications and clearance by permeation [13]. Fluids in the
inner ear are fairly stable, and majority of transport takes place via diffusion and permeation. But in the
case of a cochleostomy in scala tympani, where the substance is delivered through a hole drilled directly
into ST, advection or flow is an important parameter in describing transport, as the substance will flow
from the point of delivery out of the cochlear aqueduct which acts like a sink. So we first discuss the
governing partial differential equations for diffusion and advection within a tube, followed by permeation
(which also describes clearance) along the lines of those described by Hobbie and Roth [16]. Once we
combine these cases, we go on to describe our forward 1D model. The units of concentration are in
mg/ml (mass/volume) unless specified otherwise.
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3.1 Longitudinal Transport: Diffusion and Advection
The process of random movement of particles from a region of higher concentration to that of lower con-
centration is called diffusion. The particles involved move independently and may collide with those of
the solvent but rarely collide with each other at low concentrations. The solvent may be at rest or mov-
ing. Fick’s first law of diffusion relates the solute flux j or the amount of solute passing through unit area





Consider a cylindrical tube of certain length, L in the x direction. It has a cross sectional area S. A solu-
tion flows through it at velocity v . The concentration of the solution at any point along the length, L is c̄(x)
which represents the average concentration across that section. The volume, V over any infinitesimally
small length would be Sd x.
Figure 4: Cylindrical section of length dx and cross sectional area S, with concentration c̄(x) flowing
through it at velocity v . The volume of the section, V would be Sd x.
Since we are assuming transport (diffusion and advection) along x, the solution will not be well mixed




For non-steady state diffusion, Fick’s second law (for diffusion only) or the diffusion-advection equation
needs to be used along the x direction. This is derived from Eqn. 2 using the mass continuity equation
∂c̄(x, t )
∂t
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= 0 (4)
In scalae of small cross sectional areas, it can be assumed the concentration is radially uniform [14], so ∇
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∂x
(6)
If D is constant and v is zero, the equation reduces to Fick’s second law. We now discuss the conditions
when D may not be constant.
3.1.1 Concentration dependent diffusion
The diffusion coefficient of a solute, is a function of the temperature (T ), the viscosity of the substance
or solvent it is diffusing into (η), and its hydrodynamic radius (rH ). The viscosity and radius together
make up the friction factor of the molecule (6πηrH ). If kB denotes Boltzmann’s constant, the diffusion
coefficient can be given by the equation below.
D = kB T
6πηrH
(7)
The hydrodynamic radius is representative of the size of each molecule as it diffuses through the sol-
vent. It is directly proportional to the cube root of the molecular weight (MW) of the substance, since the
molecular weight itself is considered to be representative of the volume. If ρ represents the density of the







It can be noted that since viscosity of a solute is a function of concentration, the diffusion coefficient
would also change with any changes in concentration. In most experiments, with molecules with low
viscosity, these changes can be considered to be negligible. However, in cases where the the viscosity can
change rapidly with concentration, this might be a necessary factor to take into consideration. In the
absence of a closed form expression between the concentration and viscosity, a substitute relation may
13
be used.
Fujita provided formal solutions for a modified version of Fick’s second law with a concentration de-











c = 0, x > 0, t = 0;c = c0, x = 0, t > 0
where c0 is the the concentration infused. For the purpose of our model, we made use of one of their
provided relations so as to model the concentration dependent apparent diffusion coefficient
D(cv/v ) = D0
(1−γcv/v )2
(9)
While the units of concentration do not matter in the equation as long as its multiplication with γ is
unitless, we use cv/v which denotes concentration in terms of volume/volume. This allows us to take into
consideration the entire possible range of concentrations from 0 (solution with no solute) to 1 (solution
only made up of solute). This is equivalent to D(c), in mass/volume terms as
D(c) = D0
(1−γc/ρ)2 (10)
Where ρ is the density of the solute. In this relation, D0 is the theoretical diffusion coefficient when the
concentration of the solution tends to zero, and γ is the factor that decides at what concentration the






D0 can be calculated by making use of Eqn 7, by substituting the viscosity of the pure solvent which would
represent a concentration of zero. The Eqn 9 is simple and will be able to help us represent a diffusion
coefficient that plateaus as the concentration reaches 0 as well as when it reaches 1, in a manner similar
to a sigmoid curve.
14
3.1.2 Diffusion and Advection in a tube of varying Cross sectional area
Clifford S. Platak in his paper [18] derived Fick’s second law for diffusion within a long tube. We extend this
derivation to include a non constant diffusion coefficient as well as fluid flow through the tube. Consider
a thin tube of varying cross section S(x), such that its length is much longer than its cross sectional area
or radius at any point. Again we assume the concentration across a cross section to be well mixed at all
instances. The solution is considered to be incompressible and flowing into the tube at a volumetric flow
rate F (t ) resulting in a velocity of the fluid v̄(x, t ) at each point along the length, where v̄(x, t ) = F (t )/S(x).









jx (x, y, z, t )dS (12)
Since the diffusion coefficient is concentration dependent, it can also be considered to be a function
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Since the assumption has been made that the solution is well mixed across cross sections,
∂c̄(x, t )
∂x
= ∂c(x, t )
∂x
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, 0 ≤ x < L (16)
∂c̄(L, t )
∂x
= 0, x = L
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c̄(x,0) = c̄0(x), t = 0
This PDE represents longitudinal transport within a tube of varying cross sectional area.
3.2 Transport across a membrane: Permeation
A semi-permeable membrane allows only certain substances to pass through it, so while perilymph and
endolymph do not pass through the membranes within the cochlea, some contrast agents and drugs de-
livered into those regions do. The motion of the solute molecules are not independent of those of the
solvent, since the fluids in the inner ear are at rest, movement between compartments also take place
via diffusion. In such cases the transport is referred to as permeation and in this case the solute flux is
proportional to the intercompartmental concentration gradient
j ∝∆c (17)
j =ωRT∆c (18)
Where ω is the membrane permeability, R is the ideal gas constant and T is the temperature in Kelvin.
Since we are only concerning ourselves with the term collectively, we will denote it as the transfer coeffi-
cient K .
j = K∆c (19)
Clearance refers to the removal of the drug or contrast agent from the organ. Clearance in our model
is represented by the transfer coefficient of the membrane between the scala media and the stria vascu-
laris. While clearance is usually represented by transport out of spiral ligament (SL) to blood, we consider
clearance directly out of scala media due to the limitations in extracting concentrations out of SL. This is
possible since SL in the mouse is mostly in contact with SM and has very little contact with ST and SV.
We now take into consideration two cylindrical compartments with volumes V and V ′ and concen-
trations c̄(x, t ) and b̄(x, t ) with transport between them occurring through a membrane of area A. The
concentration in each section of length d x is considered to be radially uniform. This means that at each
point along x, the concentration is well mixed across the cross sectional area S, or instantaneous mixing
occurs across the cross section when any change in concentration occurs at any point within it.
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Figure 5: Cylindrical section of length d x and cross sectional area S, with concentration c̄(x, t ) at time t.
The section has a semipermeable membrane of area A in contact with another compartment of concen-
tration b̄(x, t ). The volume of the section, V would be Sd x.
The flux in the y direction would be
jy =−K (c̄(x, t )− b̄(x, t )) (20)
Where K depends on the physical properties of the membrane such as thickness, pore size and density,
and its units are in mm/s.
Representing the flux jy in terms of the number of moles Ny ,
∂Ny
A(x)∂t
=−K (c̄(x, t )− b̄(x, t )) (21)
∂Ny
∂t
=−K A(x)(c̄(x, t )− b̄(x, t )) (22)





(c̄(x, t )− b̄(x, t )) (23)




(c̄(x, t )− b̄(x, t )) (24)
It can be seen that the change in the number of moles of the substance is independent of the volume it is
in and is only dependent on the area of the membrane it is trying to permeate out of and the concentration
gradient between the compartments. This is due to the fact that irrespective of the size of the compart-
ments, permeation will take place till the solute is equally dispersed throughout both compartments i.e.
their concentrations are equal.
These equations for transport in the x and y directions can be combined to model transport as a whole.
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3.3 Combined model for Diffusion, Advection and Permeation
We now consider a model with all three modes of transport; concentration dependent diffusion, advection
and permeation through a tube of varying cross sectional area. The figure shows a single infinitesimal
section taken into consideration. The length of the whole tube is L and the initial concentration is c̄0(x) =
c̄(x,0).
Figure 6: Cylindrical section of length dx and cross sectional area S, with concentration c̄(x, t ) flowing
through it at velocity v . Permeation takes place through a semi-permeable membrane of area A to a
section of another compartment of concentration b̄(x, t ). The volume of the section, V would be Sd x.
Diffusion takes place in the x direction while permation takes place across y.



















(c̄(x, t )− b̄(x, t )), 0 ≤ x < L (25)
∂c̄(L, t )
∂x
= 0, x = L
c̄(x,0) = c̄0(x), t = 0
3.4 Our Model
A representation of the reduced model we use is given in the following figure. Scala tympani, and scala
vestibuli are considered to have transport only with scala media. Clearance to blood takes place out of the
spiral ligament, but we have low confidence in the concentrations extracted from the spiral ligament. The
plots tend to be noisy since the registered labelmap is very thin, which is prohibitive for the extraction.
Instead, we treat the spiral ligament as a membrane itself, so SM is considered to clear out to blood in the
scala vascularis. The semipermeable membranes between scalae, (Basilar membrane between ST and
SM, and Reissner’s membrane between SV and SM) as well as transport between SM and blood via the
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stria vascularis are represented by dashed lines. Solid lines represent bone or the inability for transport to
take place out of the scala through that boundary. Contrast agent will be delivered at a certain flow rate
Figure 7: Cross section of our 1D model, diffusion and advection are considered to take place in a direc-
tion perpendicular to the plane of the page. Dashed lines represent transport between scalae, solid lines
represent no transport
at the base of ST. The contrast agent flows out of the cochlear aqueduct, resulting in the point of delivery
acting like a constant source. Over time, the agent diffuses down the length of ST and up into SM and
SV. So from the point of delivery upto the apex, equation 25 reduces since v = 0, and from the point of
delivery down to the cochlear aqueduct, the equation will be used as is.














(c̄(x, t )− b̄(x, t )), x0 < x < L (26)
∂c̄(L, t )
∂x
= 0, x = L
c̄(x,0) = c̄0(x), t = 0


















(c̄(x, t )− b̄(x, t )), (27)




= 0, x = 0
c̄(x,0) = c̄0(x), t = 0
Equation 26 equated within each scala, will be used for the inverse model to learn the permeability
coefficient for each membrane, while 27 will be equated at the point of delivery, to learn the flow rate and
leakage rate during delivery.
3.5 Translating transport coefficients to a different solute
Given the theoretical diffusion coefficient of a solute when its concentration is zero (D0) or the permeation
coefficients, they can be scaled for other compounds using the simple relation mentioned in Eqn 7. The














We also consider the case of permeation at the membrane and treat it like diffusion across it in the y-












This means that the permeability coefficient can be treated as the ratio of coefficient of diffusion of a
solute within that membrane to the thickness of the membrane. Which implies that once the permeability
coefficient is found for a certain solute through a certain membrane, it can be scaled using the relation in
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So the scaling factor based on the molecular weights and densities of the solutes can be used as a sim-
ple method to translate the transport parameters from one molecule to another. However, in the case of
the permeation coefficients, this method does not take into account the possibility of a change in inter-
action of the molecules with the membrane structure. Also, for the diffusion coefficient, we consider γ to
be the same for the new molecule, this method assumes that the new molecules also behave in a man-
ner similar to the old solute. For instance, as new solute is pumped into the solution, its viscosity at 10%
v/v of the solution is assumed to be the same as the viscosity at 10% of the old solution, which may be
inaccurate.
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4 Quantification of compounds delivered
An important process in quantification of the contrast agent is sampling, which in our case is done using
three dimensional micro-computed tomography (µCT). While the scans provide a volumetric represen-
tation of the cochlea, it needs to be segmented based on anatomy so that sampling from the different
scalae becomes possible. Segmentation of medical images is problematic due to low contrast and fuzzy
contours. For instance, cross sections of thin structures like Reissner’s membrane are not visible in the
µCT scans used for our experiments. A solution is to use a reference image and register it to the images
that we wish to segment [9]. The resulting transformation can be applied to the corresponding labels of
the reference image so that segmentation can be achieved by performing registration. Once segmented,
the transformed labelmaps can be used to extract the medial axes so that when superimposed on the µCT
scans, extraction of intensity values and thus proportional concentrations along the length of the cochlea
is possible.
4.1 Drug infusion setup
Figure 8: Setup for drug delivery to the mouse cochlea. A volume of 5000nl of Iopamidol (Isovue) is de-
livered. The air bubbles between the volumes of Artificial Perilymph (AP) and Iopamidol prevent their
mixing and also provide a visual reference to ensure the rate of flow through the tube.
The work in this section was performed by the team of Doctors at University of South Florida in a
manner similar to that explained by Borkholder et. al [19]. Surgery was performed on the left ears of
deeply anesthetized young adult CBA/CaJ mice. A cochleostomy was drilled by hand close to the cochlear
aqueduct. The polymide infusion tube was inserted using a micromanipulator and fixed in place using
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dental cement. The mice remained anesthetized during the experiment.
Iopamidol, an iodine based contrast agent, and Artificial perilypmh were delivered through the polymide
tube connected to a 25µL syringe which was mounted in a syringe pump. Solutions of Iopamidol and arti-
ficial perilymph were separated by 10nL air bubbles which helped avoid diffusion of the solutions within
the tube and were also used as a visual guide for the flow rate.
4.2 Imaging
The work in this section was performed by the team of Doctors at University of South Florida. The for-
mation of CT images relies on the differential attenuation of photons in body tissue defined by linear
attenuation coefficients resulting in the production of contrast in CT images. To improve visibility, con-
trast agents with high attenuation constants are usually used in experiments. We use Iopamidol, an iodine
based contrast agent. Inner ear drug concentrations can be quantified over time for a given infusion pro-
tocol, by using an established relation between the image intensity and the concentration of bound iodine
in an Iopamidol solution.
A Seimens Inveon scanner was used for the experiments. Each resulting scan is of size 1024×1024×512
with each voxel of size 16×16×16 µm. Each full scan takes 20 min to complete, along with a setup time
of 10 min between each scan. So scans were taken every 30 min while the infused volumes were recorded
manually until the entire volume of Iopamidol was delivered, which was a total of 5 scans during delivery
with one more scan being taken before delivery as our baseline scan. The files from each scan were saved
as uint16 DICOM images by the scanner. Further processing was performed on these files.
4.3 Calibration
The work in this section was based on work by Haghpanahi et. al [9] and was performed by S. S. Moudgalya.
Intensities of µCT scans are quantified in Hounsfield units (HU). The transformation between the atten-
uation coefficients of air and water at STP are defined such that radio density of air is 0HU and of distilled
water is -1000HU. To determine the relationship between the Hounsfield units from the µCT scans and
the concentrations of the contrast agent, plastic tubes containing solutions of Iopamidol with concentra-
tions of organically bound Iodine ranging from 0mg/ml (i.e. saline) to 325mg/ml were imaged. A circular
region of interest around 80 pixels in diameter was used in each image region with a distinct concen-
tration to calculate the mean and standard deviation of the intensities. The HU intensities were plotted
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against the known concentrations and linear regression was used to find the relation between them. The
relation found between HU values (y) and concentration of bound Iodine in Iopamidol (x) is given by
y = 29.4133x −53.1569. It should be noted that x is not the true concentration of the agent in the solution
but the concentration of the bound Iodine in the solution that can be captured by the µCT. Based on the
physical properties provided for the compound, multiplying this value with a simple scaling factor of 2.04
will give us the true concentration of the solution.
Figure 9: Line fit to the calibration data. HU values are represented by y and concentration of organically
bound Iodine in Iopamidol are represented by x.
The image was also used to determine the sensitivity of the µCT machine. The standard deviations
of the intensities were converted to the standard deviations of the Iodine concentrations in Iopamidol
(σc ) and a graph of the ratio of noise to the bound Iodine concentration (σc /C ) was plotted against the
bound Iodine concentration (C). A power curve axb was fit to the data points and the sensitivity was
defined at the point where σc /C =1, which falls around 2.6553mg/ml. Changes in Iopamidol less than this
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amount may be treated as noise. Based on averages taken in a circular window in the calibration scans for
diameters ranging from 1 to 15, we found that a diameter of 5 voxels and above gave variations in average
which was lower than the sensitivity value. However, there is no closed form equation for sensitivity and
diameter values. A diameter of 7 voxels was chosen since it is large enough to ensure that the variations
were lower than the sensitivity and small enough that we do not overlap any bone in apical regions during
extractions.
Figure 10: Plot of σc /c vs c where c represents concentration in mg/ml and σc represents the standard
deviation of the concentration of bound Iodine. The sensitivity cut off is at 2.6553mg/ml with concentra-
tions lower than this being treated as noise.
4.4 Registration and Segmentation
The work in this section was based on initial work by X. Zhu [20] with significant modifications by S. S.
Moudgalya. Despite having high resolution, segmentation of medical images is problematic due to low
contrast, blurry contours and similar intensities for adjacent objects of interest. With the use of a reference
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Figure 11: Multistage registration is performed by registering the same set of scans at different resolutions
image and labelmaps as apriori knowledge, segmentation can be reduced to registration by applying an
equivalent transformation to the atlas labels. This is done by solving a problem to optimize the similarity
metric. A similarity metric is used to determine how well the moving image is registered to the fixed image.
We make use of Mutual information as the similarity metric which is the difference between the sum of
the individual entropies and the joint entropy.
I (A,B) = H(A)+H(B)−H(A,B) (34)
Scans of the entire mouse head are taken so a region of interest (ROI) can be determined manually.
Once determined for the baseline scan the same voxel indices can be used for the remaining scans as-
suming there is no movement of the mouse between scans. In case of movement between scans, an ROI
of the same size but a different origin is determined and the atlas is registered to each of the scans so that
at the end of the process each scan has a corresponding labelmap. We make use of Santi’s mouse cochlea
database [10] as our atlas. They consist of 2D image stacks of histology slices taken at 20µm spacing from
each other and with each slice of 5.453×5.453µm resolution.
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Figure 12: An example of the results of a segmented mouse cochlea. The red regions represent ST, green
SM and blue SV. The greyscale regions represent bony and membranous structures.
For registration, a combination of multi resolution and multi stage strategies are used. Images that
have been decimated by factors of 3 and 2 are used for rigid transformations of similarity and affine stages
where the image is rotated and scaled. The original atlas resolution is used for deformable registration
where splines are fit to try and deform the image locally. The transformations can be treated as a cascade
of systems and the resulting transform is applied to the labelmap.
4.5 Medial Axis extraction
Apart from the concentrations, the rate of diffusion within and between compartments depends on their
physical dimensions. Our model calls for the use of cross sectional areas along the length of each scala.
To aid in the extraction of concentrations as well as the cross sectional areas, the medial axis or skeleton
is required. The medial axis of a structure is the locus of centers of maximally inscribed hyperspheres.
Medial axis extraction is also referred to as skeletonization. Kerschnitzki, Kollmannsberger et al developed
a MATLAB plugin [21] based on a skeletonization work by Lee et al. [22], which describes the work given
in this section.
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Figure 13: 2D example of a rectangle with inscribed hyperspheres whose centers form the skeleton
4.5.1 Digital Topological requirements
We consider an ’object’ made up of S, a set of voxels (volume elements) with value 1, with 26-connectivity
in a binary 3D space, where each voxel p is represented by its centroid (i,j,k). The remaining voxels, with
value zero in the space S̄ are considered to be the background. For the extraction of the medial axis,
voxels need to be removed from the set S or its value set to zero. The removal of a voxel p must preserve
the topology of the space i.e. the number of objects O(S), the number of holes H(S) and the number of
cavities C (S) must remain the same. While objects are considered to be distinct disconnected subsets of
voxels, cavities are empty spaces completely surrounded by S and holes are like tunnels i.e. not completely
surrounded by S (like donuts). However holes can be difficult to define in 3D, and the checking of global
conditions for the removal of every point is computationally expensive. To help overcome these issues
certain conditions have been put forward.
4.5.1.1 Global and local Euler Formula The Euler characteristics help define a 3D hole consistently.
The Euler characteristic χ(S) is given by
χ(S) =O(S)−H(S)+C (S) (35)
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Where O(S) is the number of objects, H(S) is the number of holes and C (S) is the number of cavities in S.
To reduce the complexity, a local Euler formula G(S) can be used where
χ(S) =∑
i
G(S ∩N (pi )) (36)
G(S) = v −e + f −oct (37)
where v, e, f and oct are the number of vertices, edges, faces and octants, within S, and N (pi ) is a 3×3×3
neighborhood around voxel pi and pi εS.
4.5.1.2 Simple Border Point A point or voxel in S is considered to be a border point if it is 6-connected
to a voxel in S̄. ’Simple’ points have often been used in thinning operations for the purpose of preserving
topological conditions. A border point (p) is simple if and only if the number of connected objects and
holes for S and S̄ do not change on removal of the point. These points have been shown to have the
following properties
δG(S ∩N (p)) = 0; and (38)
δH(S ∩N (p)) = 0; or
δO(S ∩N (p)) = 0
where δ denotes the change in the neighborhood on removal of the point. Also, since the 26 neighbors of
p are connected to it, O(S ∩N (p)) is always 1 before removal of p. So if removal of p causes O(S ∩N (p))
to remain 1, we have
δO(S ∩N (p)) = 0 if and only if O(S ∩N (p)) = 1 (39)
The above conditions can be used to test simplicity.
4.5.2 Parallel Thinning Operations
While only simple border points of an object need to be deleted for the purpose of medial axis extraction,
these operations need to be performed in parallel. This may result in instances where with the sole use of
these criteria, deletion of a point may lead to deletion of the entire object. A common way to eliminate
the problem is dividing each thinning operation into 6 subcycles in a fixed order, depending on the type
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of simple border point in consideration, and checking for preservation of connectivity before and after
removal of such points. The type of a simple border point is based on its 6-connectivity to the remaining
voxels in the neighborhood i.e. up (U), bottom (B), north (N), south (S), west (W), east (E). If R is con-
sidered to denote a set of simple border points of a certain type, and Q = S −R, each of those points is
examined for path connectivity; p is only removed if voxels in Q ∩N (p) and R ∩N (p) remain connected
after its removal (O({R ∩N (p)}∪ {Q ∩N (p)}) = 1). To extract the medial surface or the medial axis, bor-
der points of S are repetitively deleted if they satisfy the above conditions until no more points can be
removed. More geometric constraints can be added based on whether a medial surface or a medial axis
needs to be extracted. But since a medial axis is usually extracted from a medial surface, we first provide
the conditions for the extraction of the surface.
In medial surface thinning, the object is thinned so that its thickness is one voxel in any one of the
three principal directions of a plane. Given an octant (N 2(p)), a plane can be considered to run through
it if any 4 vertices lie on a plane (or the points on any 2 parallel edges are all 1, and the rest are 0). This
can be done by ordering the vertices of the cube and noting the configuration based on which points are
0 and 1 as indexes in a look up table. Only a small subset (D) of the 28 configurations will denote such
planes. Apart from this, the point can also be a surface end point where instead, it can be considered that
the octant has less than three points set to 1. So a point p is a surface point if ∀i , iε{1, ...,8}
Index[N 2(pi )]εD ; or (40)
|N 2(pi )| < 3
The configuration number is represented by Index[N 2(pi )], and |N 2(pi )| denotes the number of set vox-
els in N 2(pi ). As discussed earlier, medial axis thinning extracts lines and arcs through the center of S
instead of a surface. A final condition to consider is used to prevent the removal of the end points. After
the removal of all border points of a certain type, at least 2 points need to remain within the neighborhood
(|Q ∩N (p)| ≥ 2).
Let T represent the skeletonization operation with a set order of directions(U ,B , N ,S,W,E), then T
repetitively deletes simple border points from S simultaneously while satisfying these 4 conditions.
(C 1) δG(S ∩N (p)) = 0
(C 2) O(S ∩N (p)) = 1
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(C 3) O({R∩N (p)}∪{Q∩N (p)}) = 1, where R is the set of border points that satisfy the first two
conditions C1 and C2 and Q = S −R
(C 4) (i) p does not meet the surface end point condition, |N 2(pi )| ≥ 3, or
(ii) |Q ∩N (p)| > 1 where |Q ∩N (p)| is the number of points in Q ∩N (p)
The process is continued until no such points are left.
Figure 14: An example illustrating the process of medial axis extraction of the labelmap of scala tympani.
The first image shows the original labelmap, followed by what it looks like after the axis is extracted along
with all the branches. The final images shows the pruned medial axis which the only part of the original
axis we need.
4.5.3 Pruning
Since the input object is noisy, the resulting skeleton contains multiple spurious branches that need to be
pruned. To do this, we manually fix the start and end points E and get rid of all other end points iteratively
until only the main ’trunk’ of the skeleton remains. An end point would be such a point that is connected
to only one other point indicating that it is the tip of a branch.
If p 6∈ E,
Remove p if |N(p)|<3
The process is continued until no such points are left. The condition removes a voxel if there are only
two voxels in the neighborhood of p (one more voxel apart from itself). The condition works well when
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the extracted skeleton is of single voxel thickness and has no loops, which is usually the case since the
labelmaps are open ended. In some instances where the labelmap becomes flatter like towards the apex of
a scala, the skeletonization may result in a loop. This issue can be solved with some manual intervention
where a voxel form an unwanted branch of the loop is set to zero; essentially disconnecting it and turning
it into an open branch. The pruning condition can be run on this structure once more till the single axis
is achieved.
For ST, the labelmap branches off into two small structures near the round window membrane as
seen in Fig 14. The resulting skeleton has branches near the round window membrane. This point which
is located near the cohclear aqueduct is set as the basal end point (or 0%) for ST. Similarly, in SM, we select
the basal end point to be the point closest to the RWM in ST; this occurs at a point where it takes a sharp
turn to wrap around the basal end of ST. The base point for SV is selected to be the point closest to the oval
window membrane. We chose these basal end points since we are not interested in transport that occurs
from these points out to the apex. The apical end points for all the scalae were selected as the last points
of the medial axes at the apex.
4.5.4 Reparameterization of the Medial Axis
To find the cross sectional areas and average concentrations at each point, we need to know the tangent
and normal vectors at those points along the length of the axis. Though the axis is smoother after the
removal of of the extra branches of the skeleton, the resulting medial axis is in the discrete space. We
can consider a tangent as the vector from one voxel on the medial axis to its neighbor, but this would
mean that only 26 directional vectors can be defined (one for each possible neighbor). This could result
in the extraction of cross sectional planes that have a large angular displacement from the true cross
section at than point, giving us erroneous extractions. Smoothing of this reduced axis is performed by
reparameterizing the points in terms of arclength, which means that the coordinates of the points are
each treated as functions of the length of the medial axis, x = f (l ), y = g (l ) and z = h(l ), where l is the
length. Cubic splines are fit to these points so the curves can be smoothed and the required number of
points are uniformly sampled from these curves (100 points in our case). The tangents can be calculated
by the first order differentials of these functions, so that they are not limited directionally.
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4.6 Extractions of Concentrations and physical dimensions
Concentrations can be extracted along the axis in a couple of ways, planar and volumetric. The first being
across the cross section of the plane normal to the tangent at each point; the second is in a sphere around
each point. The planar extraction is more accurate but can be susceptible to errors in the direction of
the tangent. Small changes in the direction may result in larger shifts in the position of the plane as we
move further away from the point in consideration. This susceptibility may not be problematic when we
consider small regions for concentration extractions. This process is also important for the extraction
of cross sectional areas. While being computationally less expensive, the volumetric extraction is less
accurate since it acts like a smoothing filter along the length of the axis.
4.6.1 Planar Extraction
To describe a plane at each of these points, the unit tangent vectors (T) are calculated from the first order
derivatives. The second order derivative can be used for the unit normal vectors (N). The cross product of
the tangent and normal results in a unit vector perpendicular to both of them and can be called the unit
binormal vecotr (B). These sets of 3 vectors at each point can be used to generate a transformation matrix
so that the normal and binormal are the principal axes (x and y) in the plane we are considering and the
tangent points out of it.
[N |B |T ]′Tr = I (41)
Tr = ([N |B |T ]′)−1 (42)
However using the transformation matrix directly may give rise to holes as there may be many to one
mappings of voxel (to pixel) coordinates. Instead of transforming the plane to a new space, a planar grid






xol d yol d zol d
]
(43)
The coordinates [xol d yol d zol d ] may be floating point numbers but the value at that point can be
interpolated from the vertices of the 2× 2× 2 cube the point falls in. This method is used at least once
solely on the labelmaps in the process to extract the plots of cross sectional areas along the length. Since
the new interpolated voxels fall on a single plane they can be treated as "pixels". The number of such
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Figure 15: New interpolated plane at a point along the reparameterized medial axis. The red dot shows
the point at which the medial axis is normal to the plane.
pixels in the interpolated plane in the labelmap, can be multiplied by the pixel area (16µm × 16µm) to get
the cross sectional area of the scala at that point along the medial axis. To extract concentrations, the new
interpolated labelmap and µCT planes are superimposed on each other and voxel values are averaged
only over regions where they intersect. To ensure that the extraction does not include bone, the planar
labelmap is eroded at least once before averaging is performed.
4.6.2 Volumetric Extraction
The process is fairly simple and involves using a predefined spherical mask at each point along the medial
axis. The final mask at each point is the intersection of the sphere and the whole 3D labelmap, to ensure
we do not surpass the borders. With this method, we do not need the earlier step for reparameterization
and the raw medial axis can be made use of. This method may be used preliminarily as a qualitative gauge
that tells us if the experiment was successful, but since it not only averages across the scala but also across
its length causing an unintended smoothing of the extracted HU and resulting concentration values.
For the concentration extractions, we use the planar method in the baseline and 5 subsequent scans
with a disc that is 7 voxels in diameter. The difference between those values and those of the baseline,
result in the final extracted concentration profile for each scan. In larger scalae, the difference in both the
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methods of extraction is usually small with the volumetric extraction being slightly smoother. However,
in smaller regions like spiral ligament, both methods may prove to be problematic since in either case it
is has very few voxels for averaging.
4.6.3 Baseline correction
Voxels within each scan represent not only the concentration of the contrast agent delivered to it, but also
the underlying structures. So the "concentration" values extracted from each scan need to be corrected
so that they represent only the concentrations of Iopmaidol. The intensity profiles extracted from all
the 6 scans (including the baseline) using a 7 voxel planar disc are calibrated to give the corresponding
concentration values. The resulting profile from the baseline scan is subtracted from the profiles extracted
from the remaining scans. This is called baseline correction and also helps to mitigate some of the effects




Though the model can be treated as a set of linear equations in terms of the transfer coefficients, a sim-
ple linear inversion of matrices cannot be used since the time interval for each scan is 20 minutes with
another interval of 10 minutes between each scan. The equations themselves are partial differential equa-
tions in x and t. To discretize them, ∆t needs to be less than 1 second, or the equations break down. In-
stead we apply a stochastic gradient descent approach while trying to minimize the sums of normalized
mean squared errors of each scala.







The loss is treated as a function of the parameters and they are then incremented at a rate proportional to
the derivative of the loss with respect to that parameter. We discuss the process further in this section.
5.1 Forward model: Discretization of Equations
Consider the concentration c̄(x, t ) within a scala along the length x, with cross sectional area S(x) and














(c̄(x, t )− b̄(x, t )), (45)
x0 ≤ x < L
∂c̄(L, t )
∂x
= 0, x = L
c̄(x,0) = c̄0(x), t = 0
where K denotes the transport coefficient across the membranes between scalae and b(x, t ) is the con-
centration in a neighbouring scala. The diffusion coefficient is concentration dependent as in Eqn 9. But
since the concentration is itself a function of x and t, the diffusion coefficient can also be considered a



















(c̄(x, t )− b̄(x, t )) (46)
Using product rule and discretizing the equation so that the length of the scala is divided into infinitesimal
parts of length ∆x and the difference in time steps is ∆t we get
∆c̄(n, i )
∆t















(c̄(n, i )− b̄(n, i )) (47)
For the purpose of the model, at every new instance in time, we can consider
c̄(x, t ) = c̄(x, t−1)+∆t ∂c̄(x, t )
∂t
(48)
Since each scan is taken over a 20 min period, we can simulate a similar case by averaging the above
equation over the total number of discrete time steps K it takes to reach 20 minutes, I = 60×20/∆t














c̄(n, i −1)+∆c̄(n, i )
)
(50)
C(n) is the estimated concentration averaged over 20 minutes at n, so that it can be compared to the
corresponding concentration extracted from the scans and I is the number of discrete time steps it takes
to reach 20 min.
5.2 Parameter Optimization
We assume that the loss is a function of the parameters we try to optimize. Starting with an initial esti-
mate of the transfer coefficients and D0, we run the forward model. We normalize the resulting simu-
lated concentration profiles as well as the extracted concentrations profiles with respect to the maximum
concentration observed in the scala tympani within our scans. We compare the normalized simulated
concentrations to the normalized extracted ones and calculate the loss, which is in a multidimensional
space. We look for the best possible minima in this multidimensional space by incrementally changing
the parameters at a rate proportional to the derivative of the loss (with respect to that parameter). This is
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done using a hyper-parameter called the learning rate usually denoted by α. It is used to scale the deriva-
tives and acts as a deciding factor in how fast the optimization converges.If Cscan denotes the original
extracted concentrations and Cm ax denotes the maximum concentration extracted from a voxel within









To make updates in the parameters, we require the first derivatives of the loss with respect to the re-
spective parameter. But since we use a discretized set of differential equations, calculating the derivatives
analytically would be a non trivial problem. Instead, we make an incremental change in the parameter
for the first iteration and then increment it based on the rate of change of the loss with respect to the
















L represents the loss from the current iteration and L−1 represents the loss calculated from the pre-
vious iteration.
The parameter update process is detailed in the steps below.
(1) Randomly initialize parameters K, γ and D0
(2) Initialize hyperparameters αK ,αD0 ,αγ to low values
(3) Run the forward model with the ranodmly intialized parameters
(4) Calculate the loss L for this simulation
(5) Make incremental changes in K, D0 and γ
K ← K +K ×10−4
D0 ← D0 +D0 ×10−4
γ← γ+γ×10−4
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(6) Use the new parameter values in the forward model again
(7) Calculate the loss L for this iteration
(8) If the change in loss is less than 0.01%
Save parameters and exit loop
Else update parameters again
K ← K −αK dLdK
D0 ← D0 −αD0 dLdD0
γ← γ−αγ dLdγ
Repeat from step (5)
If the initial parameter estimates selected are close to the values of a minima, the gradient descent
method will be to find those values if the values of the learning rates are small enough. If the learning
rates are too large we may overshoot the global minima and end up in another local minima. The same
process may be carried out to estimate the flow rate at each time point while taking into consideration
just the point of delivery with the initial assumption that the flow rate is equal to 32nL/min (the flow rate
for the experiment).
It must be noted that this method requires some brute force and may need to be run a few times with
varied initial values of hyperparameters and parameters before reaching an optimal solution.
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6 Results and Discussions
The parameter optimization was run on multiple datasets with each containing five 3D µCT scans (and
an extra baseline scan) taken over 140min, while 490mg/ml of Iopamidol (240mg/ml of organically bound
Iodine) was being infused at 32nl/min. Each scan took about 20 min with a set up time of 10 min between
scans. The optimization was run with randomly initialized parameters until the change in the loss was
negligible (0.01% of the loss in the previous iteration). The final parameters selected were those associ-
ated with the lowest loss. As is the case with gradient descent the selection of initial parameters (which
is random) determines whether the algorithm converges and if it does, how soon it happens. So the con-
vergence occurred within the first 10 iterations if the initial estimates of the parameters were close to the
values at the minima.
After convergence, each parameter was averaged over its respective extracted values from the exper-
iments. These values were used for all simulations thereafter. These parameters were adjusted to be
applied to other drugs as will be discussed later in the chapter.
6.1 Extracted concentration profiles
Using the planar extraction as discussed earlier, the HU values within a disc of 7 voxel diameter are av-
eraged at every point along the medial axis of each scala. Based on the calibration curve, the HU values
give us the concentration profiles along the length of each scala after baseline correction. The extracted
concentrations at 5 time points for two of our experiments normalized to the delivered concentrations
are given in the figure 16.
It can be seen that the profiles within ST show a decreasing trend in the concentration as we go along
the length, until we reach 40-50% where it almost starts to plateau. This can be attributed to the con-
centration dependent diffusion coefficient. The maximum concentration in ST represents the point of
delivery. In the first experiment, the maximum keeps increasing for each curve, instead of being close to
1. This suggests the presence of a leak, which lead us to estimating the flow rate at that point. The dip in
the profiles of the first time point at 10 min in ST are due to the presence of an air bubble which gets ab-
sorbed over time. We also note that, the concentrations within SM track those within ST. We now provide
the parameters learned and the simulated concentration profiles.
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ST SM SV
Figure 16: Normalized extracted concentrations from the 5 consecutive scans from 2 experiments, are
plotted against the length of each scala in percentage. Each curve is labeled by the mean time point of the
20 minutes over which the corresponding scan was taken. The maximum value of each curve within ST
indicate the point of delivery. The concentrations in ST for the April 9th scans (first row) show a steady
increase in the maximum value over time while in the June 21st scans, they remain fairly constant. This
could be explained by a leak that gets filled up over time. The dips in the 10min curves are due to the
presence of an air bubble that dissipates over time.
6.2 Learned Parameters
For each experiment, we learned the three transfer coefficients, KST−SM , KSM−SV and KSM−clear (where
Ki− j denotes the transfer between scalae i and j ), the average flow rate per scan, and the parameters for
the adaptive concentration dependent diffusion coefficient. The relation used for the concentration(in





D0 is the limit of the diffusion coefficient when the concentration tends to 0, and γ determines the con-
centration at which the diffusion coefficient starts to change. D0 can be theoretically calculated from the
relation mentioned earlier








where, kB is Boltzmann’s constant, N0 is Avogadro’s number, T is the temperature in Kelvin (311K), MW is
the molecular weight of the solute (777.08g/mol) and ρ is the density of the pure solute (2.204kg/L). The
viscosity η refers to the viscosity of the solution it is diffusing into, which would be perilymph in this case.
Since the viscosity of perilymph in the mouse ear is unknown, we substituted it with the available value
for the viscosity of water at 37°C which is 0.68cP. This gave us a value of D0 = 6.7×10−4mm2/s. Since this
would not be the precise value for the mouse, with our optimization we would learn both, D0 and γ. It
was observed that the value of D0 extracted from the model was 6.22×10−4mm2/s (which is close to the
value we calculated).
In his PhD thesis, Luca Fontanive [23] empirically finds the values of the diffusion coefficient of various
iodinated contrast agents as they diffuse into a solution of Trisodium Phosphate in water at 6 different
concentrations using diffusional ordered spectroscopy. It can be seen in Fig 17 that the points from his
data fall within a similar range of values as our curves and also has a similar trend. However, the points do
seem to fall off much faster than our curves as we increase the concentration. This difference is probably
since we assume diffusion through perilymph while he assumes it through a solution of TSP in water.
He suggests that at higher concentrations, Iopamidol tends to group together with TSP leading to the
formation of "aggregate" molecules with higher molecular weight and thus higher hydrodynamic radius
causing the diffusion coefficient to fall off rapidly.
The first 3 rows in table 1, show all the parameters we extracted for each experiment. The last row
compares them with the values used by Plontke et al. in their work [14]. It should be taken into account
that Plontke’s experiment was carried out for a guinea pig ear with methylprednisolone instead of Iopami-
dol. Along with Salt et al. [7, 24], they suggest that the spiral ligament plays an important role in substance
transport between scalae, with substance entering SM and SV through the ligament. However, these ob-
servations can be true for the guinea pig since the area of contact between ST and the the ligament is quite
large.However, in the case of the murine cochlea, the area of contact between the spiral ligament and ST is
negligible suggesting it may not be a major route of transport. These observations together could account
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Figure 17: The y axis has been normalized by the extracted diffusion coefficient at 0 concentration for
Iopamidol (D0 = 6.22× 10−4mm2/s. The points are based on the diffusion coefficients of Iopamidol in
a solution of Trisodium phosphate in water, studied in Luca Fontanive’s thesis[23] and the remaining
curves represent the extracted γ parameter for each experiment. In the curves, the normalized coeffi-
cient plateaus off towards 1 as the concentration tends towards zero. As the concentration begins to tend
towards 1, a state where the solution mostly consists of Iopamidol, the diffusion coefficient tends to a
much lower value which represents self-diffusion. While Fontanive’s points are close to our curves and
follow a similar trend, as we go towards a concentration of 1, their diffusion coefficient reduces much
faster. Fontanive suggests that this happens at higher concentrations in their experiments since TSP
forms a larger number of aggregate molecules with Iopamidol effectively increasing the size and radius
of the particles in the solution. The black line shows the maximum value of concentration delivered in
our experiments, so all the values of the diffusion coefficients used by the model will lie to the left of this
line.
for the fact that their value for KST−SM is lower than KSM−SV .
Initially we assume that the flow rate in scala tympani is 32nL/min, but our experiments have shown
that instead of the concentrations being constant at the point of delivery, they increase sharply over time
for some experiments. It can be seen in the first time point of 10min in the extracted concentration profiles
in 18(a), that the concentration at the peak (point of delivery) is much lower but levels off in the later time
points, which suggests the presence of a leak. So along with the diffusion and transfer parameters, we
decided to learn the flow rate. Since each scan gives us a time resolution of 20 min, we found the average













April 9th 0.71 0.35 0.042 6.23 -0.93
June 21st 1.2 0.29 0.032 6.22 -0.91Adaptive curve
Aug 20th 1.1 0.52 0.033 6.23 -0.79
Mean values 1.01 0.38 0.035 6.226 -0.87
Plontke’s Experiment∗ 0.4 0.6 0.018∗∗
Table 1: Parameters extracted using our adaptive diffusion coefficient curve.
∗ The last row shows values used by Plontke et al. in their experiment for methylprednisolone.
∗∗ They assume clearance out of spiral ligament so the value in the last cell in the last row refers to KSL,clear
(a) (b) (c)
Figure 18: The extracted profiles on the left show the lower concentration at the first time point. The sim-
ulated profile (right) was adjusted after learning the inflow rate (center).We learned the average inflow
rate each scan in the extracted profile by assuming the same flow rate over every 20 min cycle and in-
terpolating between them. The rate of leakage is essentially the inflow rate subtracted from the flow rate
administered by the pump.
our simulations to the extractions much better. This can then be subtracted from the initial estimate
of 32nL/min to give us the rate of leakage of the substance. We suggest the leak takes place out of the
cochleostomy site, before stabilizing.
6.3 Loss Sensitivity Analysis
As mentioned earlier, in gradient descent the parameters are updated based on the rate of change of the
loss function with respect to the parameter. So it could be useful to see how sensitive the loss function is to
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the optimized parameters. To do this we compute the second order derivative of the loss function at those
set of parameters in a process similar to Section 5.2. This tells us the degree of curvature of the function in
the direction of that parameter. A large positive value indicates that the curvature is sharply concave and
a small change in the value of this parameter would result in considerable changes in the loss. Conversely
a small positive value indicates that the minima is fairly flat in the direction of that parameter and even










April 9th 7.83×10−4 1.5×10−3 1.36×10−2 3.20×10−7
June 21st 7.3×10−4 2.4×10−3 1.92×10−2 6.99×10−8
Aug 20th 10×10−4 1.5×10−3 1.72×10−2 5.62×10−7
Table 2: The table shows the values of the second order derivative of the loss with respect to the parameter.
It is evaluated at the minima that our optimization has reached.
Table 2 shows the values of the second order derivative of the loss for each experiment with respect
to the extracted parameters evaluated at the local minima i.e. evaluated at the corresponding values ex-
tracted in Table 1. We see that the second order derivative is much lower for γ than for the transfer coeffi-
cients, indicating that its value is quite flexible in comparison to the other parameters. This is supported
by the fact that during our simulations, we mostly stay in the flat part of the diffusion curve where small
changes in γ may not affect our accuracy by much. Though to a lesser extent this can also be observed
for KST−SM , while KSM−SV and KSM−clear have much higher values indicating that they are much more
sensitive than the other parameters.
6.4 Simulating Extracted concentration profiles
The parameters learned above change over iterations as they go through the optimization multiple times.
Once the change in loss is negligible, the average of each of those parameters across experiments is used
for any forward simulations henceforth. Here we show the simulated concentration profiles associated
with the averaged parameters shown in Table 1 for the 21st June scans.
Fig 19 compares the extracted concentration profiles to the simulated ones while providing the error
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ST SM SV
Figure 19: The plots in each column are for ST, SM and SV respectively. Each row subsequently shows the
extracted concentration, the simulated concentrations using the mean of the parameters and the corre-
sponding errors. The y-axes of all the plots represent normalized concentrations (the last row represents
errors in terms of normalized concentrations) and the x-axes represent % along length.
plots. Ignoring the plots at the first time point which have a large dip the extracted concentrations due
to the presence of the air bubble, the simulated plots match the extracted plots well. The RMSE for the
concentration profiles is 8.9%.
Alec N. Salt came up with a model, FluidSim[13] , that takes into consideration other parts of the
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cochlea such as the spiral ligament, the organ of corti, the spiral ganglion, etc, but it only considers a
single fixed diffusion coefficient. The model also makes used of fixed half-times (t1/2) to represent inter-
scala communications for each membrane. Making use of the equations used in the model, which are
based on his previous works [7, 24], a relation between the transfer coefficients (K) and the half-times can
be calculated at each point along the length. If we consider a small cross section of volume V out of which







The term 0.693t1/2 is known as the rate constant. This term is multiplied by ∆c across the membrane to get
the change in concentration over time. We see that the relation would provide a rate constant that varies
across the length of the scala. Salt handles this by allowing for the half times to be normalized by area. It
must also be noted that the same half-time cannot be used to represent transport across the membrane
in both directions. For example, the half time for transport to take place from SM-SV is not the same as
that from SV-SM, and must be scaled by the ratio of the cross sectional areas (or volumes) of SM to SV.
Salt manages this by asking the user to specify half-times only in certain directions, like one can set the
half-times from organ of corti to ST but not vice versa. This is not an issue faced by our model due to the
use of a transfer coefficient which remains independent of direction.
We compare our results to Salt’s in FluidSim v3.14 by attempting to replicate an ideal case of our ex-
periments where we would have no leak. With the perfusion option at 32nL/min for 490mg/ml, FluidSim
was run for a solute of molecular weight 777.08g/mol with the total delivery time of 140 min. To estimate
half-times that could be used in FluidSim, we used Eqn 58. For interscala half-times we estimated their
values at the first point along the length. This allowed for them to be scaled in FluidSim, based on the cross
sectional area as we go down the length (using the option for "scaling based on area"). The half-time for
SM-SV was 6.2min (V = 5.7×10−3mm3, A = 27.2×10−3mm2), SM-OC was 6.8min (V = 5.7×10−3mm3, A
= 9.9×10−3mm2), with OC-ST set to a minimal amount (0.1 min indicating nearly immediate transport
between the organ of corti and ST). This was done since FluidSim did not have the provision to represent
transport between ST and SM directly. Since FluidSim allows the use of a mean half-time for clearance the
mean values of the area of contact and the volume of the scala were used to get a half time of 70min (V =
4×10−3mm3, A = 17.7×10−3mm2). The results generated by FluidSim and by our model shows curves that
fall in similar ranges of values, but the plots generated by by our model fall with a sharper gradient. The
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ST SM SV
Figure 20: The plots show the concentrations in ST, SM and SV at 140 min, simulating Iopamidol delivery
using our model (in blue), and those generated using Salt’s FluidSim software (in red). We used the average
values of the extracted transport parameters in our model. The half times for FluidSim were calculated
from our transfer coefficients based on Eqn 58. The half-times used for interscala transport were 0.1 min
for transport from organ of corti (OC) to ST, 6.2 min from SM to OC, 6.8 min from SM to SV while setting
the option for scaling by area. For clearance out of SM, the average half-time set was 70 min. While the
0% in ST for FluidSim is assumed to be the tip of the hooked region near the round window, the curves
displayed here have been adjusted so that the cochlear aqueduct is aligned for both the models. The
resulting concentrations have been compared to our most consistent experiment with no leakage that
was conducted on June 21st. It can be seen that our simulations are able to provide better estimates with
lower errors, while FluidSim simulations result in higher errors.
curves simulated by FluidSim show a slower gradient with higher apical values in all the scalae with SM
and SV showing lower basal values but uniform plots throughout. While we do include a concentration
dependent diffusion coefficient in our model, its range of values (4.5×10−4mm2/s to 6.22×10−4mm2/s)
is small and comparable to the constant coefficient used in FluidSim (5.9×10−4mm2/s). It must be noted
from the equations used in our model that we scale our transfer coefficients and clearance by multiplying
them by the area of contact of the membrane in consideration and dividing the volume of the cross sec-
tion out of which we are diffusing (as in Eqn 24). However FluidSim does not take into account the area
of contact and scales the interscala communication half-times only by the cross sectional areas. There is
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no provision to do so for the clearance and an average half time is used. This probably explains why Flu-
idSim overestimated the concentrations in this experiment. The inclusion of the area of the membrane
and volume of the cross section to describe interscala communication in our model results in an increase
in transport out of scala tympani at as we travel from the base to the apex, since the basilar membrane is
wider at the base than at the apex. These terms are also used in our model to represent clearance out of
scala media as well. When compard to FluidSim which uses only a single average clearance half time, it
results in FluidSim underestimating clearance since the volume scala media reduces gradually from base
to apex. Thus the higher rate of interscala transport and clearance out of scala media can be attributed to
the way our transport parameters are scaled based on the dimensions of the scalae and the membranes
in consideration.
We also find the errors between the simulations and the extracted concentrations from the June 21st
scans as seen in Fig 20. The profiles from this experiment show the most consistent flow rate over the
5 scans. The simulations have a constant flow rate of 32nL/min over the whole range of time. Also in
the extractions, each plot represents 20min while in FluidSim we can only show a single time point at
140min. However this should not affect the comparison too much since after such long periods of time
the profiles would be nearing equilibrium. The RMSE (at 140min) for our plots is lower at 8% while it is
18% for FluidSim.
6.5 Maintaining a Target Therapeutic window
As mentioned before, the therapeutic window is an important concept in pharmacokinetics which essen-
tially is the range of concentration of the drug over which it can act as an effective treatment. Below this
range the drug is ineffective and above it, it may prove to be toxic. Instead of injecting continuously or
administering a single bolus injection, it may be more suitable to deliver the drug in pulses, so that it is
allowed to diffuse out towards the apex before new drug can be delivered at the base again, allowing us
to stay within the therapeutic window. Our model can be made use of to adjust the delivery method so
that drug is used efficiently while staying within a hypothetical therapeutic window. We adjusted our flow
rate so that it was pulsatile, allowing concentration to even out across the scala before pumping drug back
into the base. We used the averaged parameters from Table 1 for our diffusion and transfer coefficients,
by minimizing the difference in basal-apical concentration, while maximizing apical concentration.
Let us consider CLT and CU T to be the lower and upper thresholds allowed by a notional therapeutic
window and the basal-apical difference ∆C . First, using our mean extracted parameters, we deliver a pul-
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Figure 21: The figure shows maximum concentrations at the base (red and green surface) and the mini-
mum concentrations at the apex (blue surface) recorded at equilibrium for each combination of on and
off times. The black portions of each surface represent those concentrations that do not fall within the
notional therapeutic window. A suitable combination for Ton and To f f would require the corresponding
points in both curves to be colored and for the difference between them to be low. One such combination
is for an on time of 1 min and an off time of 7 min.
sating profile near the cochlear aqueduct in our simulated cochlea. The on and off times of the pulsatile
profile are varied by 1 min increments. The minimum and maximum concentrations within ST at equi-
librium are saved for each combination. For this example, these min and max values are essentially the
basal and apical concentrations at the end of the on cycle and at the end of the off cycle respectively, since
solute reaches the base directly, and takes time to reach the apex.
We assume the delivered concentration to be 490mg/ml at 8nL/min for 2000min. The time interval is
enough to reach equilibrium. If we were to assume a hypothetical case where CLT = 0.25 of the concen-
tration in the delivery tube and CU T = 0.75, we could find those combinations of Ton and To f f where ∆C
is minimum. In Fig. 21, we plot the maximum base values and the minimum apex values where C<0.75
and C>0.25 respectively (shown by the colored regions in the surface plots). The valid set of Ton and To f f
that would stay within these thresholds, is the intersection where both the plots stay in color. Of these,
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Figure 22: The figure shows concentrations in the scala tympani after equilibrium has been reached for
490mg/ml of Iopamidol (777.08g/mol) being delivered at 8nL/min continuously, as well as using a square
pulse delivery which is on for 1min at 8nL/min and off for 7min. The solid black lines represent the
notional therapeutic window. All concentrations must fall within these two lines so as to be effective as
a drug and non-toxic at the same time. The solid and dashed colored lines show the basal and apical
concentrations respectively. Red lines represent the concentration profiles over time due to continuous
flow while blue shows those due to a suitable pulsatile profile. It can be seen that the pulsatile profile
provides a more suitable delivery method with the basal (max) and apical (min) concentrations falling
within the notional therapeutic window. But the profile at the base of ST for the continuous delivery, falls
outside the window, which would lead to strong side effects.
Ton = 1mi n and To f f = 7mi n have the lowest difference with the maximum basal concentration at 0.38.
Fig 22 shows the comparison between the resulting concentrations due to pulsatile profile after equilib-
rium which occurs by 1200 min since the on and off times are lower. In the basal and apical concentrations
due to the pulsatile profiles with the flow rate at 8nL/min, stay within the notional therapeutic window
while the continuous profile leads to excess drug delivered at the base which could lead to side-effects,
while not providing much of an added advantage within the apex. By using a pulsatile profile with an on
time for 1 min and off time for 7 min, it is possible to reduce the total drug delivered by 87.5% while reduc-
ing potential toxicity when compared to a continuous delivery profile, allowing a reduction in reservoir
size.
The above example can be extended so that we maximize the apical concentration while minimizing
the basal apical difference and maintaining the therapeutic window for all scalae. It may also be possible
to come up with more complex but optimal non periodic delivery profiles. These problems would require
more sophisticated optimization techniques and is left to future work.
51
6.6 Extension to other compounds
To compare our model to FluidSim, we simulate an experiment for the mouse cochlea in our model by
scaling the averaged Iopamidol parameters extracted earlier and compare it to similar simulations from
FluidSim where default values of half times for transport are used. The setup assumes 10mM (equivalent
to 3.74mg/ml) of methylprednisolone is infused through a cochleostomy near the RWM at 10nL/min. In
FluidSim, it is assumed that the interscala transport and half-time values for guinea pigs can be applied to
mice. So for our case of the mouse cochlea, we make use of the default half times employed in FluidSim;
interscala communication from SM to SV as 60 min and clearance at 110 min, we assume transport half
times from SM to OC of 60 min, from OC to ST 0.1 min. All other forms of interscala communication were
left unset, which FluidSim assumes to indicate infinity, or that no transport takes across that membrane.
To determine the scaling factor for the parameters for methylprednisolone to be used in our model, we
make use of the density of the new compound (ρnew = 1.3g /cc3) along with its molecular weight. The






where MWol d and ρol d are the molecular weight and density of Iopamidol and MWnew and ρnew are the
molecular weight and density of Methylprednisolone.
We observed that in our model the concentration dependence of the diffusion coefficient does not
come into play at such low concentrations where it is close to D0. We also observed that our effective
diffusion coefficient of 6.65×10−4mm2/s is close in value to the one used in FluidSim 7.84×10−4mm2/s.
On converting the half-times used in FluidSim to corresponding transfer coefficients, by using the scaling
factor in expression 59, we found that while the values for clearance were comparable, the transfer coef-
ficent equivalents of the default half times used in FluidSim were much lower than our estimates of the
transfer coefficients (which were scaled versions of the coefficients extracted for Iopamidol), indicating
that interscala transport for the experiment in FluidSim was assumed to be much lower.
Looking at Fig 23, we see that for the FluidSim plots, with interscala transport being slower and the
diffusion coefficient being constant in FluidSim, longitudinal movement of the solute is freely allowed to
take place via diffusion while the amount of solute entering or leaving the comparment due to transverse
permeation is low, this results in a flatter profile as substance moves towards the apical regions while only
small amounts get added to or removed from it. While this is easily observed in SM, the concentration
profile in SV is also fairly flat except for the slight increase towards the apex. This may be due to some
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solute entering SV from ST via the helicotrema but the differences in the apical values of ST and SV may
suggest a deficiency in the details of the model. Conversely in our model, while the diffusion coefficient
can be treated as constant, transport between compartments takes place at a higher rate, so some sub-
stance can move out of or into another scala before it reaches the apex, resulting in a higher gradient in
the concentration profile of ST. This also results in the maintenance of a small peak in SM which tracks the
peak in ST, and maintains the gradient in SV. We noted earlier that the transfer coefficients in our model
was scaled by the area of contact of the membrane and the volume of the section in consideration, while
the half-times for interscala communication as used in FluidSim only take the cross sectional areas (rep-
resentative of the cross sectional volume) into account. This suggests that the transport surface area to
volume ratio is an important factor and may be used to scale the half times between animals. We consid-
ered the case of two small cylinders with cross sectional areas similar to those of the mouse and guinea
pig, and attempted to scale the half times based on the ratio of a section of the curved surface area to the
volume. The section was considered to be subtended by the same angle meaning that proportions were
maintained while scaling between the mouse and guinea pig. This however suggested that the scaling of
half-times is only dependent on the ratio of the radii of the 2 cylinders. The approximate radius in the
basal region of ST is 0.203mm in the mouse, while it is 0.683 in the guinea pig. The ratio of the two is 3.15
which is used to scale down the half-times from the guinea pig to the mouse. We performed a simulation
with these scaled half times but found that it only made a very small difference in the profiles in ST and

















Default Scaled Default Scaled
SM-ST* 60 20 0.10 0.30 1.08 5.5
SM-SV 60 20 0.036 0.108 0.40 5.4
SM-clear 110 36 0.024 0.072 0.038 70
D or D0 7.84×10−4mm2/s 6.65×10−4mm2/s
γ -0.87
Table 3: Transport parameter estimates for Methylprednisolone are shown in this table. The first column
shows default vales of half times given for a mouse in FluidSim (which are the same half times as guinea
pig). The corresponding equivalent transfer coefficients are calculated using Eqn 58. When compared
to the translated transfer coefficients used by our model, they are much smaller indicating very low in-
terscala transport. The fourth column shows the corresponding half times for the transfer coefficients
used by our model. They seem to be much lower than the default values set in FluidSim, thus suggesting
transport that occurs more freely. This makes sense considering the size of the molecule is smaller than
Iopamidol.
Using our estimates of the parameters for methylprednisolone, we also simulate an experiment similar
to Section 6.5. We saved out the minimum and maximum values for each combination of on and off times
of a pulsatile profile, and determined that for a notional therapeutic window of CLT = 0.25 and CU T =
0.75 for 10mM of methylprednisolone delivered in the base of ST, a pulsatile profile with on times of 2
min and off times of 12 min would be most suitable. It must be noted that such a window is very small
(representing a range of only 1.87mg/ml) at such low concentrations. It can be maintained within such
small windows since the concentration dependence of the diffusion coefficient can be ignored at such low
concentrations, meaning that more solute is available to diffuse out towards the apex. Using a pulsatile
profile as shown by the blue lines in Fig 24 that stay within the black lines of the notational therapeutic
window could prove to be safer and more efficient. With this pulsatile profile with an on time of 2 min and
off time of 12 min, 85.7% less drug can be delivered when compared to a continuous delivery, reducing
required reservoir volumes and potential toxicity.
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Figure 23: The plots show concentrations in ST, SM and SV of the mouse cochlea with 10mM of methyl-
prednisolone being delivered to it at 10nL/min for 140min. The curves for the RIT model were generated
using a scaled version of the average transport parameters extracted from Iopamidol experiments. Half
times for interscala communication in FluidSim were assumed to be 60 min for transport from SM to SV
and from SM to OC; and 0.1 min from OC to ST, with the option for scaling by area set. The average clear-
ance half time out of SM was assumed to be 110.9 min. These half-times were the same as those used
for guinea pig. We also plotted results for scaled versions of the half times. We see that the curves differ
significantly in concentration values for SV and SM. Scaling the half times improves the fit for ST but has
a minimal effect on SM and SV.
ST SM SV
Figure 24: The figure shows delivery of methylprednisolone at 10mM or 3.74mg/ml of methylprednisolone
are delivered through a cochleostomy at 10nL/min in a manner similar to section 6.5. Using a pulsatile
profile at the base, with an on time of 2 min and off time of 12 min, our concentration profiles (blue lines)
are able to stay within the window (black lines). Using a continuous flow (red lines) would have been
detrimental in this case as the basal concentration would have exceeded the therapeutic window.
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7 Conclusions
We made use of micro-computed Tomography as a non-invasive method for sampling the concentra-
tion of the contrast agent within the principal compartments of the cochlea. Using the extracted profiles
we were able to extract transport parameters in our 1D model for each experiment, and simulate con-
centration profiles similar to the ones sampled from the scans, confirming the reasonable accuracy of
our models. Using averages of the parameters extracted, and given the upper and lower concentration
thresholds of a notational therapeutic window, we were also able to simulate concentration profiles that
optimized a pulsatile delivery to minimize base to apex concentration gradients while maximizing apical
concentrations.
The diffusion model in this work was based solely on the principal three scalae of the cochlea, scala
tympani, scala vestibuli and scala media. This was primarily due to the fact that intensity values extracted
from much smaller regions like the organ of corti and the spiral ligament (SL) could not be trusted because
the number of voxels in these regions were very low and were not enough to overcome the presence of
noise. The labelmap for SL would often overlap with regions of high intensity suggesting the presence of
bone. We had difficulty in determining whether SL was well registered in the labelmaps for the µCT scans
due to the low contrast and blurred contours inherently present in CT scans. An eventual possibility in
overcoming these issues is to use higher resolution CT scanners like "nano-CT" scanners [25] which would
further improve spatial resolution giving us more voxels to average over. A limitation of these scanners for
now is that they require samples to be of the order of a millimeter. Another approach would be to look
into more sophisticated methods for registration. Work is currently underway to use machine learning
on multiple sets of the µST scans, so that the registrations can be more robust. This work will also tell us
more about the variability in cochlear anatomy between various mice.
By making assumptions that were as close as possible and to the conditions in one our experiments
for Iopamidol, we compared our forward model to FluidSim, which is considered to be the gold standard
in cochlear fluid models. While the profiles for both sets of curves were close, ours showed lower values
in the apices. These differences were attributed to the fact that we scaled our interscala transport param-
eters by the area of contact of the membrane in consideration as well as the volume of the cross section
leading to increased transport towards the apex of the scalae. Our profiles seemed to match the extracted
concentrations from our experiment better than FluidSim.
We illustrated the extension of our model to other drugs based on the molecular weight and density
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of the solute, but our results for methylprednisolone differed from simulations in FluidSim. The con-
centrations in this experiment were very low so the diffusion coefficient was fairly independent of it. On
translating our average parameters extracted from Iopmaidol to Methylprednisolone, the resulting val-
ues suggested that the the rate of transport between scalae should have been higher than that observed
in FluidSim. The profiles generated by FluidSim were much flatter than those generated by our model,
suggesting that the drug would be allowed to move freely towards apical regions within each scala while
only small amounts got added to or removed from it due to interscala communication. The discrepancies
could be explained by many factors. One possibility is the way half times are set in FluidSim. Most of the
work related to the simulator is done on guinea pigs, but the values for the half-times for the guinea pig are
assumed to be the same as those for the mouse. This may not be an accurate representation of transport
in the mouse cochlea, and more investigation is required to determine how half times are scaled between
animals. Another possibility is that the method we use for the extension of our model may not be suitable
for all compounds. More work needs to be done to determine how this translation needs to be handled
depending on the chemical and physical properties of the drug for longitudinal transport. For the purpose
of interscala transport, the properties of the membranes involved also need to be studied as they can be
selective based on the molecule that is being transported (for example the basilar membrane is ionically
selective when it comes to Na+ and K+ ions). This may severely affect their semi-permeability.
In the results, we observe that with the current method of delivery near the base, if the drug is being
injected over a long period of time, the concentration at the apex will reach equilibrium at a lower concen-
tration than the base since there will always be drug/contrast agent delivered to the base while transport
and clearance mechanisms limit total drug transport to the apex. This may make it difficult to deliver so
that the substance stays within the therapeutic window. Other methods of delivery can also be looked
into, where a a long perforated capillary tube, that extends from the base to the apex is inserted through
the round window membrane. Delivery can take place at multiple points along the length of ST so that
much higher concentrations can be reached along the entire length.
In our experiments regarding the maintenance of a notional therapeutic window we use a simple
method of running the forward simulation with different combinations of on and off times for a pulsatile
profile and noting down the minimum and maximum values of the concentrations achieved at equilib-
rium within the scala tympani. By minimizing the differences between the minimum and maximum val-
ues while staying within the notational window, we select a suitable profile for safe drug delivery. This
method is fairly simple but during selection of the appropriate pulsatile profile only considers the scala
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tympani. To ensure that the treatment is effective, we need to target the hair cells and other structures
on the basilar membrane, for which the window will have to be maintained within scala media as well.
While concentrations in scala media do track those in scala tympani and fell within our notional window,
investigation of sophisticated optimization techniques to determine a suitable delivery profile, may be
necessary especially when the window has a much smaller range when compared to the range of concen-
trations in consideration.
The work presented in this thesis explores the possibility of extending a model derived from exper-
iments based on the non invasive sampling of one compound delivered to the murine cochlea to other
drugs. It also investigates how drug delivery profiles can be adjusted to maintain therapeutic windows
even after the model has been extended. These contributions show the importance of the work in future
development of safe, effective and efficient drug delivery paradigms that could be used in the treatment
of acute and chronic types of hearing loss.
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